Investors in Medical

venture arm.

ArchiMed SAS is a private equity firm specializing investing in buyouts and growth capital of small to mid cap companies and lower mid-market. The firm seeks to invest in small and medium-sized companies in the healthcare sector with a focus on care and wellness including homecare, wellness centers, telemedicine, and hospital outsourcing services; medtech including medical devices and disposables, implants, diagnostics, healthcare information technology, life science tools, hygiene products, and medtech distributors; biopharma including specialty bioPharma companies, active pharmaceutical ingredients producers, contract manufacturing, animal health, contract research organizations, medical affairs, OTC products and wellness product manufacturers; and public health including health at work, food safety, environmental security, forensic. It prefers to invest in Europe with a focus on Western Europe including France, the United Kingdom, and Switzerland. The firm typically invests between €5 million ($6.22 million) and €15 million ($18.65 million) per transaction but the full range for the firm is between €2 million ($2.49 million) to €50 million ($59.7 million) or higher, alone or with co-investors. It invests in companies with revenues between €5 million ($6.22 million) and €100 million ($124.33 million), but with the ability to go beyond. The firm takes both minority and majority stakes, mostly in unlisted companies. ArchiMed SAS was founded in 2014 and is based in Lyon, France with an additional office in Paris, France.

We’re (not just) investors. We’re (more than) advisors. We’re (beyond) connectors. Ben Franklin Technology Partners combines the best practices of early stage investing with a higher purpose – to lead the region’s technology community to new heights, creating jobs and transforming lives. For over 30 years, Ben has been the leading seed stage capital provider for the region’s technology sectors, investing over $170 million in more than 1,750 regional technology companies, many of which have gone on to become industry leaders. Ben Franklin has also launched university/industry partnerships that accelerate scientific discoveries to commercialization, and has seeded regional initiatives that strengthen our entrepreneurial community.

A Rockstart Accelerator is an intensive startup program that helps entrepreneurs take their companies from early traction to the global market in 6 months. It provides investment, office space, highly specialized knowledge, and access to a broad network of international mentors, partners and investors. During this program, the startups enroll in 30+ workshops on Lean Startup, Growth Strategies, Fundraising, Sales, PR & Marketing, Team & Personal development, Legal & Finance and more. After 100 days the entrepreneurs present their companies to investors, partners, entrepreneurs and industry journalists in Demo Day. Finally, in a month-long program in Silicon Valley startups expand their international network and learn from the world’s leading tech scene.

Founded in 1993, WI Harper Group is an investment firm based in Beijing. The firm invests in start-up companies.

Qiming Venture Partners invests in young, fast-growing companies across China in the media and internet, IT, consumer and retail, healthcare, and clean technology sectors. we are early to growth stage venture capital firm with offices in Shanghai, Beijing and Hong Kong. Since their debut in 2006, we have established their selves as a leading investment firm in China and currently manage four funds with over $1 billion in assets.

Insight Partners is the most trusted scale-up firm in the software industry. Their team of industry-leading experts partner with companies to drive extraordinary success that is fueled by know-how, grit, and hands-on collaboration. Founded in 1995, Insight currently has over $20 billion of assets under management and has cumulatively invested in more than 300 companies worldwide. Across their people and their portfolio, they encourage a culture around a core belief: growth equals opportunity.

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovations in Europe, particularly through links with many institutes. research and prestigious hospitals.

Foresight Group is an alternative asset manager with a strong 30-year track record and specific expertise in environmental and solar infrastructure and private equity. Foresight Group is a leading independent infrastructure and private equity investment manager which has been managing investment funds on behalf of institutions and retail clients for 30 years. With current assets under management of over £2.2 billion, raised from the UK and international private and high-net-worth individuals, family offices, pension funds and other institutional investors, Foresight strives to generate increasing dividends and capital appreciation for its investors over the long term. Foresight has offices in UK, USA, Italy, and Australia.

StartUp Health is investing in a global army of Health Transformers to achieve health moonshots. StartUp Health is on a 30-year mission to collaborate with entrepreneurs to improve the health and wellbeing of everyone in the world. Since 2011, StartUp Health has been investing in a global army of entrepreneurs -- called Health Transformers -- to achieve health moonshots: Access to Care, Cost to Zero, Cure Disease, End to Cancer, Women’s Health, Children’s Health, Nutrition and Fitness, Brain Health, Mental Health and Happiness, Addiction, Longevity, and Pandemic Response. StartUp Health has the world’s largest health innovation portfolio with more than 330 companies across six continents and 26 countries and is backed by leading investors including Advocate Aurora Health, Chiesi, Steve Case, Mark Cuban, Esther Dyson, Brad Feld, GuideWell, Jason Finger, Jerry Levin, Kaiser Permanente, Masimo, Novartis, Otsuka, and Ping An.